Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2012
08/16/2012WO2012075376A3 Lyophilized viral formulations
08/16/2012WO2012071324A3 Pharmaceutical compositions
08/16/2012WO2012070071A9 Compounds and their use
08/16/2012WO2012027473A3 Immunogenic compositions comprising alphavirus vectored dengue virus e protein antigens
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120209012 Compounds, compositions and methods
08/16/2012US20120208895 Composite material with properties of self-healing and release of active ingredients, for biomedical applications
08/16/2012US20120208877 Skin treatment in antiseptic thin film form with silver
08/16/2012US20120208871 Use of toll-like receptor and agonist for treating cancer
08/16/2012US20120208870 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/16/2012US20120208857 Pharmaceutical Compositions
08/16/2012US20120208856 Heterocyclic Benzoxazole Compositions as Inhibitors of Hepatitis C Virus
08/16/2012US20120208817 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/16/2012US20120208789 Hydroswellable, segmented, aliphatic polyurethanes and polyurethane ureas
08/16/2012US20120208788 Tetracycline Compounds
08/16/2012US20120208787 Crystalline form of fosamprenavir calcium
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120208781 Aminoglycoside dosing regimens
08/16/2012US20120208780 Hybrid nanomaterials consisting of pseudorotaxanes, pseudopolyrotaxanes, rotaxanes, polyrotaxanes, nanoparticles and quantum dots
08/16/2012US20120208779 Macrolide synthesis process and solid-state forms
08/16/2012US20120208778 Avermectins and milbemycins for the treatment, prevention or amelioration of flavivirus infections
08/16/2012US20120208774 Method for inhibiting "melanoma inhibitory activity" mia
08/16/2012US20120208751 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
08/16/2012US20120208746 Genetic markers associated with response to cyclophilin-binding compounds
08/16/2012US20120208745 Treatment of hiv
08/16/2012US20120208744 Anti-microbial agents and compositions and methods of production and use thereof
08/16/2012US20120208260 Novel lactobacillus plantarum and composition comprising the same
08/16/2012US20120207854 Metal polysulfide-complex with biological and chemical activity
08/16/2012US20120207853 Methods of treating or preventing influenza associated illness with oxidative reductive potential water solutions
08/16/2012US20120207845 Pharmaceutical composition of nanoparticles
08/16/2012US20120207840 Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer
08/16/2012US20120207828 Large dose ribavirin formulations
08/16/2012US20120207825 Pharmaceutical compositions for reducing alcohol-induced dose dumping
08/16/2012US20120207823 Pharmaceutical pellets comprising modified starch and therapeutic applications therefor
08/16/2012US20120207822 Compositions and methods for treatment of cardiovascular disease
08/16/2012US20120207812 Skincare compositions comprising salicyclic acid
08/16/2012US20120207811 Textile material for management of skin health complications associated with skin folds, and its method of use
08/16/2012US20120207799 Oral delivery vehicle and material
08/16/2012US20120207796 Polymeric drug delivery compositions and methods for treating ophthalmic diseases
08/16/2012US20120207789 Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
08/16/2012US20120207786 Functional influenza virus-like particles (vlps)
08/16/2012US20120207785 Process for preparing an influenza seed virus for vaccine manufacture
08/16/2012US20120207784 Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
08/16/2012US20120207782 Hiv dna vaccine regulated by a caev-derived promoter
08/16/2012US20120207781 Dimensional analysis of saccharide conjugates with gpc & sec mals
08/16/2012US20120207780 Vaccine Composition
08/16/2012US20120207779 Anaplasma phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma
08/16/2012US20120207778 Nucleic acids and proteins from streptococcus groups a and b
08/16/2012US20120207777 Detoxified escherichia coli immunogens
08/16/2012US20120207776 Conserved escherichia coli immunogens
08/16/2012US20120207774 Immunization of fish with plant-expressed recombinant proteins
08/16/2012US20120207766 Intracellular toll-like receptors pathways and axonal degeneration
08/16/2012US20120207765 Chemokine receptor antagonists and use thereof
08/16/2012US20120207762 Stable pharmaceutical formulations
08/16/2012US20120207760 Compositions and Methods for the Therapy and Diagnosis of Influenza
08/16/2012US20120207752 Methods for modulating il-33 activity
08/16/2012US20120207725 Mesenchymal stem cell incorporating a nucleotide sequence coding tgfb, and uses thereof
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/16/2012US20120207709 Hbv antisense inhibitors
08/16/2012US20120207703 Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
08/16/2012US20120207700 Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing at a site of treatment
08/16/2012US20120207670 Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody
08/16/2012CA2826774A1 Hepatitis c virus inhibitors
08/16/2012CA2825495A1 Antigenic gly1 polypeptides
08/16/2012CA2825493A1 Antigenic gly1 polypeptide
08/15/2012EP2487243A2 RNAI modulation of RSV and therapeutic uses thereof
08/15/2012EP2487187A2 Human cytomegalovirus neutralising antibodies and use thereof
08/15/2012EP2487176A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
08/15/2012EP2487168A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487167A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487166A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487165A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487164A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487163A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487162A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487161A1 Modulators of pharmacokinetic properties of therapeutics
08/15/2012EP2487157A1 Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use
08/15/2012EP2486931A1 Therapeutic agent for influenza virus infectious diseases
08/15/2012EP2486134A1 Use of toll-like receptor and agonist for treating cancer
08/15/2012EP2486054A2 Recombinant antibodies against h1n1 influenza
08/15/2012EP2486044A2 Antibacterial aminoglycoside analogs
08/15/2012EP2485764A2 Selectively disrupted whole-cell vaccine
08/15/2012EP2485752A2 Enterotoxigenic e. coli fusion protein vaccines
08/15/2012EP2485729A1 Treatment with cholinergic agonists
08/15/2012EP2285393B1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
08/15/2012EP2249866B1 Use of an acetylsalicylic acid salt for the treatment of viral infections
08/15/2012EP2146988B1 New 4,8-diphenyl-polyazanaphthalene derivatives
08/15/2012EP1898914B1 Quinoline derivatives as antibacterial agents
08/15/2012EP1773790B1 Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
08/15/2012EP1705182B1 Antitumoral and antiviral peptides
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012CN1976938B Thienopyrazole derivative having PDE7 inhibitory activity
08/15/2012CN1748791B Haemorrhagic E, coli 0157:H7 vaccine for human and livestock prevention and preparing method
08/15/2012CN1688322B Antiseptic solutions containing silver chelated with polypectate and EDTA
08/15/2012CN102639520A Sialochimeric compounds
08/15/2012CN102639504A Heterocyclic antiviral compounds
08/15/2012CN102639149A Secreted aP2 and methods of inhibiting same
08/15/2012CN102639129A Antimicrobial compositions containing free fatty acids
08/15/2012CN102639116A New oral formulations for tetrapyrrole derivatives
08/15/2012CN102639101A Method for manufacturing a silica powder coated with an antibacterial agent, and topical dermatological composition including same
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 1798